Vistagen therapeutics reports q3 loss per share $0.15

Vistagen therapeutics reports fiscal 2020 third quarter financial results and provides cns pipeline overview.vistagen therapeutics inc qtrly loss per share $0.15.
VTGN Ratings Summary
VTGN Quant Ranking